(Q45723549)

15 December 2017

Mechanisms of complement activation by crystalline cholesterol (English)

1 reference

15 December 2017

Vogt W

1

1 reference

15 December 2017

von Zabern I

2

1 reference

15 December 2017

Damerau B

3

1 reference

15 December 2017

Hesse D

4

1 reference

15 December 2017

Lühmann B

5

1 reference

15 December 2017

Nolte R

6

1 reference

15 December 2017

1 February 1985

1 reference

15 December 2017

1 reference

15 December 2017

22

1 reference

15 December 2017

2

1 reference

15 December 2017

101-106

1 reference

Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Activation of the alternative pathway of complement by microcrystalline cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Function of the activated fourth component of complement (C4b) in activation of C2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

Chain structure of cobra venom factor from Naja naja and Naja haje venom

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2885%2980003-1

7 January 2021

10.1016/S0161-5890(85)80003-1

Identifiers

DOI

1 reference

15 December 2017

1 reference